Head to Head Comparison: INVO Fertility (NASDAQ:IVF) and Revolutions Medical (OTCMKTS:RMCP)

Revolutions Medical (OTCMKTS:RMCP) and INVO Fertility (NASDAQ:IVF) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their profitability, dividends, analyst recommendations, earnings, institutional ownership, risk and valuation.

Profitability

This table compares Revolutions Medical and INVO Fertility’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Revolutions Medical	N/A	N/A	N/A
INVO Fertility	-417.02%	N/A	-92.42%

Analyst Recommendations

This is a summary of current ratings and price targets for Revolutions Medical and INVO Fertility, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revolutions Medical	0	0	0	0	0.00
INVO Fertility	1	0	0	1	2.50

INVO Fertility has a consensus price target of $4.00, suggesting a potential upside of 463.30%. Given INVO Fertility’s stronger consensus rating and higher probable upside, analysts plainly believe INVO Fertility is more favorable than Revolutions Medical.

Insider & Institutional Ownership

12.0% of INVO Fertility shares are owned by institutional investors. 10.5% of Revolutions Medical shares are owned by company insiders. Comparatively, 0.7% of INVO Fertility shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Revolutions Medical has a beta of -0.43, meaning that its stock price is 143% less volatile than the S&P 500. Comparatively, INVO Fertility has a beta of 2.66, meaning that its stock price is 166% more volatile than the S&P 500.

Valuation and Earnings

This table compares Revolutions Medical and INVO Fertility”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revolutions Medical	N/A	N/A	N/A	N/A	N/A
INVO Fertility	$6.53 million	0.76	-$9.10 million	($630.29)	0.00

Revolutions Medical has higher earnings, but lower revenue than INVO Fertility.

Summary

INVO Fertility beats Revolutions Medical on 6 of the 9 factors compared between the two stocks.

About Revolutions Medical

Revolutions Medical Corporation, a development stage company, is engaged in the design, development, and commercialization of auto retractable vacuum safety syringes in the United States and internationally. The company develops RevVac auto retractable vacuum safety syringe, which is designed to reduce accidental needle stick injuries and lower the spread of blood borne diseases. It is also developing a suite of magnetic resonance imaging software tools consisting of RevColor, Rev3D, RevDisplay, and RevScan that are designed to enhance general diagnostic confidence through education and research use. The company sells its products to acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons through distributors. Revolutions Medical Corporation was founded in 1996 and is headquartered in Charleston, South Carolina.

About INVO Fertility

INVO Bioscience, Inc., together with its subsidiary, a healthcare services fertility company, provides assisted reproductive technology solutions worldwide. It offers INVOcell, a medical device that allows fertilization and early embryo development to take place in vivo within the woman’s body. The company was founded in 2007 and is based in Sarasota, Florida.